Evidence map›Paper›PMID 21677133›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Limiting CDR-H3 diversity abrogates the antibody response to the bacterial polysaccharide α 1→3 dextran.

Tamer I Mahmoud, Harry W Schroeder, John F Kearney

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Tamer I MahmoudDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Harry W Schroeder
John F Kearney
University of Alabama at Birmingham · US

Funding

IMMUNOLOGIC DISEASES AND BASIC IMMUNOLOGYT32AI007051 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Laurie Ellen Harrington · 1985 to 2026
$13.1M
Regulation of B cell Clonal Diversity and Its Role in DiseaseR01AI014782 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 1985 to 2020
$7.1M
The role of Immunoglobulin CDRH3 in Autoimmune DiseaseR01AI048115 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2000 to 2010
$3.1M
HLA Region and KIR Genomics in Common Variable Immune DeficiencyU01AI090902 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2010 to 2014
$2.9M
Terminal Transferase and Lymphocyte DevelopmentR01AI045794 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 1999 to 2008
$2.9M
Role of IG CDR-H3 in Responses to HIV VaccinesR01AI090742 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2010 to 2013
$1.5M
Role of immunoglobulin CDR-H3 in heterosubtypic immunity to influenza virusR21AI088498 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2010 to 2011
$401k
The Role of Immunoglobulin CDRH3 in Autoimmune DiseaseR56AI048115 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2012 to 2012
$366k
NIAID NIH HHS AI045794-33NIAID NIH HHS AI088498NIAID NIH HHS AI090742NIAID NIH HHS AI090902NIAID NIH HHS AI48115NIAID NIH HHS R01 AI014782NIAID NIH HHS R01 AI045794NIAID NIH HHS R01 AI048115NIAID NIH HHS R01 AI090742NIAID NIH HHS R21 AI088498NIAID NIH HHS R56 AI048115NIAID NIH HHS T32 AI007051NIAID NIH HHS U01 AI090902
6 · The paper itself

Abstract

Anti-polysaccharide Ab responses in mice are often oligoclonal, and the mechanisms involved in Ag-specific clone production and selection remain poorly understood. We evaluated the relative contribution of D(H) germline content versus N nucleotide addition in a classic oligoclonal, T-independent Ab response (α 1→3 dextran [DEX]) by challenging adult TdT-sufficient (TdT(+/+)) and TdT-deficient (TdT(-/-)) gene-targeted mice, limited to the use of a single D(H) gene segment (D-limited mice), with Enterobacter cloacae. D-limited mice achieved anti-DEX-specific levels of Abs that were broadly comparable to those of wild-type (WT) BALB/c mice. Sequence analysis of the third CDR of the H chain intervals obtained by PCR amplification of V(H) domain DNA from DEX-specific plasmablasts revealed the near universal presence of an aspartic acid residue (D99) at the V-D junction, irrespective of the composition of the D(H) locus. Although WT mice were able to use germline D(H) (DQ52, DSP, or DST) gene segment sequence, TdT activity, or both to produce D99, all three D-limited mouse strains relied exclusively on N addition. Additionally, in the absence of TdT, D-limited mice failed to produce a DEX response. Coupled with previous studies demonstrating a reduced response to DEX in TdT(-/-) mice with a WT D(H) locus, we concluded that in the case of the anti-DEX repertoire, which uses a short third CDR of the H chain, the anti-DEX response relies more intensely on sequences created by postnatal N nucleotide addition than on the germline sequence of the D(H).

Indexed as

Antibody DiversityAmino Acid SubstitutionAnimalsAntibodies, BacterialBase SequenceComplementarity Determining RegionsDextransEnterobacter cloacaeGene Rearrangement, B-LymphocyteImmunoglobulin Heavy ChainsMiceMice, Inbred BALB CMolecular Sequence DataPolysaccharides, Bacterialalpha-1,3-dextranAntibodies, BacterialComplementarity Determining RegionsDextransImmunoglobulin Heavy ChainsPolysaccharides, Bacterial

Identifiers

PMID21677133
PMCPMC3210069
OpenAlexW1994138829

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.